OrbiMed Raises $550 Mn FundVC CircleIn December it made its debut investment in India by picking up a stake in Bangalore-based clinical research organisation Ecron Acunova. ...
stake
Max India in demand as Goldman Sachs to take 9.4% stake - India Infoline.com
Max India in demand as Goldman Sachs to take 9.4% stakeIndia Infoline.com... life insurance (Max New York Life Insurance), and clinical research (Neeman Medical International). Max India's other businesses are specialty plastic ...and more »
EIH extends rally on buzz Analjit Singh to hike stake - India Infoline.com
EIH extends rally on buzz Analjit Singh to hike stakeIndia Infoline.comAnaljit Singh's Max India group which has interests in healthcare, life insurance, clinical research, specialty plastic products and healthcare staffing ...Oberoi may sell large stake to Max's SinghLivemintall 24 news articles »
Oberoi may sell large stake to Max's Singh - Livemint
Oberoi may sell large stake to Max's SinghLivemintMax India is a diversified coglomerate with business interests in specialty plastic products, healthcare, life insurance and clinical research services.and more »
JM Financial Private Equity invests R... - Reuters India
JM Financial Private Equity invests Rs 35 cr in DiagnoSearchReuters IndiaSome major private equity fundings in clinical research space include Aureos India's Rs 18.5 crore investment in Accutest Research Labs in 2006 and Sequoia ...JM Financial's fund buys stake in DiagnoSearch Life SciencesIndopiaall 3 news articles »
JM Financial Private Equity Invests R... - VC Circle
JM Financial Private Equity Invests Rs 35 Cr in DiagnoSearchVC CircleDiagnoSearch is a clinical research firm and will use the funds for organic and inorganic expansion. Private equity firm JM Financial India Fund has ...JM Financial's fund buys stake in DiagnoSearch Life SciencesIndopiaall 2 news articles »
IFC to invest Rs 150 crore in Max India - Reuters India
IFC to invest Rs 150 crore in Max IndiaReuters India, India... IFC may get a 4-5% stake in the company. The stock closed at Rs 146.75 on Tuesday. Max India has a presence in areas like life insurance (a JV with New York Life), healthcare, clinical research, specialty plastics and health staffing. Continued...
Pfizer To Raise Stake In Indian Subsidiary - Chemical & Engineering News
Calcutta TelegraphPfizer To Raise Stake In Indian SubsidiaryChemical & Engineering News... Stock Exchange and the National Stock Exchange of India, is worth approximately $136 million. Pfizer Ltd. manufactures and distributes prescription drugs as well as pet and poultry medicines. The company also performs research and clinical trials. ...Novartis in hiring mood - in China FiercePharmaall 71 news articles
Piramal Health up 13% on Sanofi stake buy - Economic Times
Piramal Health up 13% on Sanofi stake buyEconomic Times, IndiaIt also conducts clinical trials and has a diagnostics arm. The pharma firm had hived off its new drug research unit into a separate subsidiary last year and the deal with Sanofi does not involve the research arm, said another person. ...
Piramal Life defers fund-raising plans - Business Standard
Piramal Life defers fund-raising plansBusiness Standard, India - 11 hours agoUnlike most other drug research companies in India, Nicholas Piramal plans to take forward its drugs as far as close to the commercialisation stage. ...Piramal puts plans for selling stake in R&D firm on hold Financial Expressall 2 news articles

